MiMedx Can Launch Phase 3 IND Trial for Achilles Tendonitis
MiMedx received permission to proceed with an Investigational New Drug Phase III clinical trial of AmnioFix® Injectable in the treatment...
MiMedx received permission to proceed with an Investigational New Drug Phase III clinical trial of AmnioFix® Injectable in the treatment...
Bioventus received FDA premarket approval for DUROLANE single-injection hyaluronic acid to treat pain associated with knee osteoarthritis....
Orthocell announced recruitment of the first patient in a clinical trial investigating Ortho-ATI® to treat rotator cuff tendinopathy....
Medtronic launched a long-term global clinical study to collect prospective data on INFUSE® bone graft in posterolateral and transforaminal lumbar...
Kuros Biosciences received FDA 510(k) clearance to market MagnetOs synthetic bone graft putty as an autograft extender in the posterolateral...
Regentis Biomaterials received CE Mark approval for a GelrinC biodegradable implant based on denatured human fibrinogen for the treatment of articular...
Active Implants enrolled the 100th patient in clinical trials evaluating the NUsurface® Meniscus Implant to treat persistent knee pain from damaged...
Studies indicate that Anika Therapeutics’ HYALOFAST® scaffold + autologous adult MSCs present a viable option to treat knee cartilage lesions, regardless of...
MiMedx filed to initiate an Investigational New Drug Phase III clinical study comparing AmnioFix® Injectable to saline placebo in the treatment of Achilles Tendonitis....
MiMedx commenced a Phase III study to evaluate AmnioFix Injectable allograft vs. placebo in the treatment of Plantar Fasciitis. ...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.